Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0600

-6.3%

Nov 10 3:45 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: jm2i123	12/14/2013 10:28:18 AM
	Read Replies (1) of 13111

Hi Everyone. Still here too. Bought a few thousand more shares 2 weeks ago. I expect a bit of a pull back early in the week but institutions in my view are going to increase their positions. FDA process is pretty clear and PVCT well locked in. My bet is the company, with Eric Wachter on the clinical data front and their dedicated FDA consultants know who they are talking to, precisely about what (SPA, BTD, etc..) and must have been preparing for months for this and in "partnership" with the FDA for the final hearings taking place. I will be very satisfied with an SPA. Stock will jump to $4. Then it's Nasdaq. Who cares if it takes another 2 years for $10. I would be well off. oh I can wait for that. I have all the time in the world.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next